Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day : A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-01-01
著者
-
Cornely Oliver
Klinikum Der Universitat Zu Koln Klinik I Fur Innere Medizin Studienzentrum Infektiologie Ii
-
Bethe Ullrich
Department Of Internal Medicine
-
Diehl Volker
Department Of Internal Medicine I
-
Ullmann A
Johannes-gutenberg-universitat Mainz Medizinische Klinik Iii
-
REICHERT Dietmar
Stadtische Kliniken Oldenburg
-
ULLMANN Andrew
Johannes-Gutenberg-Universitat Mainz, Medizinische Klinik III
-
CORNELY Oliver
Department of Internal Medicine I
-
WICKE Thomas
Department of Internal Medicine I
-
SEIFERT Harald
Institute of Medical Microbiology, Immunology and Hygiene, Kliikum der Universitat zu Koln
-
SCHWONZEN Martin
St. Walburga Krankenhaus, Meschede
-
REICHERT Dietmar
Klinikum Oldenburg, Oldenburg
-
KARTHAUS Meinolf
Ev. Johannes Krankenhaus, Medizinische Klinik II
-
BREUER Kai
Department of Internal Medicine I
-
SALZBERGER Bernd
Department of Internal Medicine I
-
FATKENHEUER Gerd
Department of Internal Medicine I
-
Seifert Harald
Institute Of Medical Microbiology Immunology And Hygiene Kliikum Der Universitat Zu Koln
-
Karthaus Meinolf
Ev. Johannes Krankenhaus Medizinische Klinik Ii
-
Schwonzen Martin
St. Walburga Krankenhaus Meschede
関連論文
- Treatment of invasive fungal infections in clinical practice : a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole
- Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day : A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
- Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site